Ceribell(CBLL.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Ceribell
CBLL.US
CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders to record and store EEG signals generated by the headband.
1.378 T
CBLL.USMarket value -Rank by Market Cap -/-

Financial Score

22/01/2026 Update
B
Health Care EquipmentIndustry
Industry Ranking30/175
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-373.40%E
    • Profit Margin-63.35%E
    • Gross Margin88.28%A
  • Growth ScoreB
    • Revenue YoY37.93%A
    • Net Profit YoY-45.11%D
    • Total Assets YoY323.99%A
    • Net Assets YoY1335.53%A
  • Cash ScoreC
    • Cash Flow Margin-157.86%D
    • OCF YoY37.93%A
  • Operating ScoreB
    • Turnover0.67B
  • Debt ScoreA
    • Gearing Ratio17.76%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    LIVE MARKETS-Europe hitches a ride on the TACO rally

    Europe's STOXX 600 index rose 1.1% on Thursday, boosted by a rally in the U.S. following President Trump's tariff rollback. The auto sector led gains, with Renault up 3.3% and Volkswagen up 1.5%. However, Ubisoft shares plummeted 33% due to a major reorganization. Computacenter surged 10.2% after a positive trading update, while Telenor rose 8% after selling a stake in True. Conversely, Carl Zeiss Meditec fell 8.9% after reporting lower earnings expectations for FY 2025/2026.

    Reuters·
    DE
    VOW3
    0.00%
    Reuters·
    DE
    VOW3
    0.00%

    Online training course on Supplier Qualification in Life Science on May 6th-7th, 2026, offers 12 CPD hours. Strengthen quality systems in pharmaceutical, biotechnology, medical device industries. Regulatory compliance emphasized.

    An online training course titled "Best Practices for Supplier Qualification in Life Science" will be held in Dublin on May 6th-7th, 2026, offering 12 CPD hours. The course aims to strengthen quality systems in the pharmaceutical, biotechnology, and medical device industries, focusing on supplier qualifications and audits to ensure compliance with regulatory standards, including those set by the FDA.

    Unusual Whales·
    Unusual Whales·

    Inventor from Dublin, Ohio creates Pre Cancerous Spray for cryotherapy treatment, aiming to reduce overspray.

    In Pittsburgh on January 21, 2026, an inventor from Dublin, Ohio, shared the inspiration behind creating the PRE CANCEROUS SPRAY. The inventor expressed a desire for a more efficient application of liquid nitrogen or liquid nitrous oxide during cryotherapy. The innovative design aims to minimize overspray during the process.

    Unusual Whales·
    Unusual Whales·

    Inventor creates backpack (CLM-856) to secure mobile IV machine, providing freedom for child with cancer.

    In Pittsburgh on January 21, 2026, a parent shared their personal experience of caring for their child with cancer who needs constant IV treatment at home. They expressed the need for a better solution to allow their child to move around and participate in activities while receiving 24/7 intravenous therapy.

    Unusual Whales·
    Unusual Whales·

    New Medicare policy may harm patients instead of fraudsters

    A new Medicare policy set to take effect on January 1, 2026, may limit access to chronic wound treatments, potentially harming patients instead of targeting fraud. This policy could endanger many seniors and veterans in Arizona's 6th District, who are at high risk for diabetic foot ulcers and related complications. The treatments, which utilize skin substitutes, are crucial for healing and preventing serious complications. Congressman Juan Ciscomani emphasizes the need for Medicare to revise its fee schedule to ensure continued access to these life-saving treatments, advocating for patients' needs over fraud prevention measures.

    Thehill·
    Thehill·
    © 2026 Longbridge｜Disclaimer